Search results
Results From The WOW.Com Content Network
Amlodipine works partly by vasodilation (relaxing the arteries and increasing their diameter). [10] It is a long-acting calcium channel blocker of the dihydropyridine type. [10] Amlodipine was patented in 1982, and approved for medical use in 1990. [12] It is on the World Health Organization's List of Essential Medicines. [13]
Emergency medicine: Symptoms: Slow heart rate, low blood pressure, nausea, vomiting, sleepiness [1] [2] Complications: Cardiac arrest [2] Usual onset: Within 6 hours [2] Causes: Too much calcium channel blockers either by accident or on purpose [3] Differential diagnosis: Beta blocker toxicity [1] Treatment
Hypertension medications – such as amlodipine Hypnotics , or soporific drugs, commonly known as sleeping pills. Tranquilizers – such as zopiclone (Zimovane), or the benzodiazepines such as diazepam (Valium) or nitrazepam (Mogadon) and the barbiturates , such as amobarbital (Amytal) or secobarbital (Seconal)
[But] some patients might find the medication makes them sleepy—in that case, it can be taken at night before bed.” (The reason why is just down to your own biology and how you're personally ...
We live in a culture where resorting to medication tends to be the first-line treatment. Most people only know. Skip to main content. 24/7 Help. For premium support please call: ...
Treatment of excessive daytime sleepiness (EDS) relies on identifying and treating the underlying disorder which may cure the person from the EDS. Drugs like modafinil , [ 22 ] armodafinil , [ 23 ] pitolisant [ 24 ] (Wakix), sodium oxybate (Xyrem) oral solution, have been approved as treatment for EDS symptoms in the United States.
Amlodipine/olmesartan, sold under the brand name Azor, among others is a fixed-dose combination medication used to treat high blood pressure. [5] It contains amlodipine , as the besilate, a dihydropyridine calcium channel blocker , and olmesartan medoxomil , an angiotensin II receptor blocker .
The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release.